Author: "Ren, Lanqi" / Database: Unpaywall - Searchworks@Jio Institute Digital Library Search Results

Searchworks

Select search scope, currently: Articles

Catalog

books, media & more in Jio Institute collections

Articles

journal articles & other e-resources

Your search keyword '"Ren, Lanqi"' showing total 7 results

Start Over Author "Ren, Lanqi" Database Unpaywall

7 results on '"Ren, Lanqi"'

1. Role of N6‑methyladenosine in the pathogenesis, diagnosis and treatment of prostate cancer (Review)

Author: Pan, Junjie, primary, Tong, Fei, additional, Ren, Ning, additional, Ren, Lanqi, additional, Yang, Yibei, additional, Gao, Feng, additional, and Xu, Qiaoping, additional
Published: 2024
Full Text: View/download PDF

2. Cost-effectiveness of Trastuzumab emtansine and Capecitabine plus lapatinib in adjuvant treatment of Human Epidermal Growth Factor Receptor 2– Positive Metastatic Breast Cancer in China

Author: Yang, Yibei, primary, Ren, Lanqi, additional, Ren, Ning, additional, Pan, Junjie, additional, and Xu, Qiaoping, additional
Published: 2024
Full Text: View/download PDF

3. Cost-effectiveness of Metronomic chemotherapy vs Weekly Intravenous Paclitaxel in patients with ER+/HER2-Metastatic Breast Cancer

Author: Ren, Ning, primary, Xu, Qiaoping, additional, Ren, Lanqi, additional, Yang, Yibei, additional, and Pan, Junjie, additional
Published: 2024
Full Text: View/download PDF

4. RNA m6A methylation regulators in liver cancer

Author: Xu, Qiaoping, primary, Ren, Ning, additional, Ren, Lanqi, additional, Yang, Yibei, additional, Pan, Junjie, additional, and Shang, Hongkai, additional
Published: 2024
Full Text: View/download PDF

5. Ferroptosis: a new promising target for hepatocellular carcinoma therapy

Author: Xu, Qiaoping, primary, Ren, Lanqi, additional, Ren, Ning, additional, Yang, Yibei, additional, Pan, Junjie, additional, Zheng, Yu, additional, and Wang, Gang, additional
Published: 2023
Full Text: View/download PDF

6. Cost-Effectiveness Analysis of talazoparib Maintenance Treatment for patients with germline BRCA1/2 mutated HER2-negative advanced breast cancer in China and the US

Author: Xu, Qiaoping, primary, Pan, Junjie, additional, Ren, Ning, additional, Ren, Lanqi, additional, Yang, YiBei, additional, and Wang, Gang, additional
Published: 2023
Full Text: View/download PDF

7. Economic evaluation of third-line neratinib plus capecitabine versus lapatinib plus capecitabine with HER2+ metastatic breast cancer

Author: Ren, Lanqi, primary, Ren, Ning, additional, Zheng, Yu, additional, Yang, Yibei, additional, and Xu, Qiaoping, additional
Published: 2023
Full Text: View/download PDF

Catalog

Books, media, physical & digital resources

See catalog results